Costa T - Search Results

1

Passive Alzheimer's immunotherapy: A promising or uncertain option?

Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B. Høilund-Carlsen PF, et al. Among authors: costa t. Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5. Ageing Res Rev. 2023. PMID: 37414156 Review.

2

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls.

Høilund-Carlsen PF, Revheim ME, Costa T, Kepp KP, Castellani RJ, Perry G, Alavi A, Barrio JR. Høilund-Carlsen PF, et al. Among authors: costa t. Diagnostics (Basel). 2023 Jul 3;13(13):2254. doi: 10.3390/diagnostics13132254. Diagnostics (Basel). 2023. PMID: 37443645 Free PMC article.

3

Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.

Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B. Høilund-Carlsen PF, et al. Among authors: costa t. Ageing Res Rev. 2024 Jan;93:102173. doi: 10.1016/j.arr.2023.102173. Epub 2023 Dec 15. Ageing Res Rev. 2024. PMID: 38104639 Free article. Review.

4

A Bayesian Reanalysis of the Phase III Aducanumab (ADU) Trial.

Costa T, Cauda F. Costa T, et al. J Alzheimers Dis. 2022;87(3):1009-1012. doi: 10.3233/JAD-220132. J Alzheimers Dis. 2022. PMID: 35404286 Clinical Trial.

5

Retrospective Bayesian Evidence of Null Effect in Two Decades of Alzheimer's Disease Clinical Trials.

Costa T, Manuello J, Cauda F, Liloia D. Costa T, et al. J Alzheimers Dis. 2023;91(2):531-535. doi: 10.3233/JAD-220942. J Alzheimers Dis. 2023. PMID: 36442201

6

Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.

Costa T, Premi E, Liloia D, Cauda F, Manuello J. Costa T, et al. J Alzheimers Dis. 2023;95(3):1059-1065. doi: 10.3233/JAD-230589. J Alzheimers Dis. 2023. PMID: 37638445 Clinical Trial.

7

Six actions to improve detection of critical features for neuroimaging coordinate-based meta-analysis preparation.

Manuello J, Costa T, Cauda F, Liloia D. Manuello J, et al. Among authors: costa t. Neurosci Biobehav Rev. 2022 Jun;137:104659. doi: 10.1016/j.neubiorev.2022.104659. Epub 2022 Apr 9. Neurosci Biobehav Rev. 2022. PMID: 35405181 Review.

8

BACON: A tool for reverse inference in brain activation and alteration.

Costa T, Manuello J, Ferraro M, Liloia D, Nani A, Fox PT, Lancaster J, Cauda F. Costa T, et al. Hum Brain Mapp. 2021 Aug 1;42(11):3343-3351. doi: 10.1002/hbm.25452. Epub 2021 May 15. Hum Brain Mapp. 2021. PMID: 33991154 Free PMC article.

9

Linking neuroanatomical abnormalities in autism spectrum disorder with gene expression of candidate ASD genes: A meta-analytic and network-oriented approach.

Camasio A, Panzeri E, Mancuso L, Costa T, Manuello J, Ferraro M, Duca S, Cauda F, Liloia D. Camasio A, et al. Among authors: costa t. PLoS One. 2022 Nov 28;17(11):e0277466. doi: 10.1371/journal.pone.0277466. eCollection 2022. PLoS One. 2022. PMID: 36441779 Free PMC article.

10

CBMAT: a MATLAB toolbox for data preparation and post hoc analyses in neuroimaging meta-analyses.

Manuello J, Liloia D, Crocetta A, Cauda F, Costa T. Manuello J, et al. Among authors: costa t. Behav Res Methods. 2023 Aug 1. doi: 10.3758/s13428-023-02185-3. Online ahead of print. Behav Res Methods. 2023. PMID: 37528293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,532 results

Search Page